Beyond Bulls & Bears

Assessing Potential US Health Care Reforms Ahead of an Election Year
Equity

Assessing Potential US Health Care Reforms Ahead of an Election Year

Franklin Equity Group’s Evan McCulloch discusses why we might see US legislation on drug pricing before the 2020 US Presidential Election. He also explains why he’s optimistic about the outlook for the biotechnology and pharmaceutical industries.

New Innovation Spurring a Biotech Rejuvenation
Equity

New Innovation Spurring a Biotech Rejuvenation

“We’ve seen medical advancements and breakthroughs in drugs and health care technology reach unprecedented levels in recent years. We foresee this potentially long cycle of innovation persisting.” – Evan McCulloch, Franklin Equity Group

The Politics of Health Care
Equity

The Politics of Health Care

“There have been huge breakthroughs in gene therapy as well as in the area of cancer treatment. Major waves of innovation are a reflection of the exponential leaps in basic research and our understanding of human biology, which are now bearing fruit.” - Evan McCulloch, Franklin Equity Group

3 Reasons Why Investors Should Ignore Political Threats to Biotech
Perspectives

3 Reasons Why Investors Should Ignore Political Threats to Biotech

Drug prices have been thrown back into the headlines after politicians jumped into the fray over the most recent accusations of price gouging. As ...

The Politics—and Potential—of US Biotech
Perspectives

The Politics—and Potential—of US Biotech

The US biotech industry has been in the sickbed so far this year, with many of its indexes in negative territory year to date, even as the overall ...

In the Know: What’s Ailing Biotech?
Equity

In the Know: What’s Ailing Biotech?

In the Know: Professionals at Franklin Templeton Investments offer a quick but insightful update on a pressing investment topic. Concerns about ...

Biotech Boom – or Bubble?
Equity

Biotech Boom – or Bubble?

Currently, there are many exciting products in the pharmaceutical and biotech space producing clinical data that show a meaningful change for patients.

A Biotech and Pharmaceutical RX

A Biotech and Pharmaceutical RX